UPDATE 1-Pfizer to buy Medivation in $14 bln deal
August 22, 2016 at 07:24 AM EDT
Aug 22 (Reuters) - Pfizer Inc said on Monday it would buy U.S. cancer drug company Medivation Inc in a deal valued at about $14 billion to boost its oncology portfolio.